Matthew J Hobson
Private Equity Investor bei Catalio Capital Management LP
Profil
Matthew (Matt) Hobson, PhD is a Principal at Catalio Capital Management LP where he primarily covers investments in therapeutics and diagnostics for their venture and private credit strategies.
He currently represents Catalio on the board of Lassen Therapeutics and as a board observer of Anagenex, Iambic Therapeutics, Octant Therapeutics, and Pink Dx.
Matt joined Catalio at its founding in 2020.
Prior to joining Catalio, Matthew was a Postdoctoral Fellow at the Johns Hopkins School of Medicine where he also earned a PhD in biophysics and biophysical chemistry, applying a variety of structural, biochemical and protein engineering methods to study proteins involved in DNA replication and repair.
Matt also holds a B.S.
in chemistry and physics from Emory University.
Aktive Positionen von Matthew J Hobson
| Unternehmen | Position | Beginn |
|---|---|---|
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | 01.01.2020 |
Ausbildung von Matthew J Hobson
| Emory University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
